Management of bacterial infections in cirrhosis

https://doi.org/10.1016/S0168-8278(12)60002-6Get rights and content

Summary

Bacterial infections are very frequent in advanced cirrhosis and become the first cause of death of these patients. Despite numerous experimental data and significant advances in the understanding of the pathogenesis of sepsis in cirrhosis, the outcome remains poor. Classical diagnostic parameters such as C-reactive protein and SIRS criteria have less diagnostic capacity in the cirrhotic population, often delaying the diagnosis and the management of bacterial infection. Prompt and appropriate empirical antibiotic treatment of infection and early resuscitation of patients with severe sepsis or septic shock are essential in determining patient's outcome. A strategy of careful restriction of prophylactic antibiotics to the high-risk populations could reduce the spread of multidrug resistant bacteria. This review is focused on the currently recommended diagnostic, therapeutic and prophylactic strategies for bacterial infections in the cirrhotic population.

References (126)

  • F Schepis et al.

    Procalcitonin is the best diagnostic and prognostic marker of sepsis in decompensated cirrhotic patients

    J Hepatol

    (2010)
  • J Castellote et al.

    Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips

    Hepatology

    (2003)
  • MA Parsi et al.

    Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis

    Gastroenterology

    (2008)
  • G Soriano et al.

    Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management

    J Hepatol

    (2010)
  • J Acevedo et al.

    Current efficacy of recommended empirical antibiotic therapy in patients with cirrhosis and bacterial infection

    J Hepatol

    (2009)
  • J Cabrera et al.

    Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage

    Gastroenterology

    (1982)
  • E Ricart et al.

    Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients

    J Hepatol

    (2000)
  • R Terg et al.

    Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study

    J Hepatol

    (2000)
  • M Navasa et al.

    Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

    Gastroenterology

    (1996)
  • L Ruiz del Arbol et al.

    Cardiovascular, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis

    Hepatology

    (2003)
  • J Fernández et al.

    Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis

    J Hepatol

    (2004)
  • A Nazar et al.

    Effects of albumin administration in patients with cirrhosis and bacterial infections other than SBP. A randomized controlled study

    J Hepatol

    (2009)
  • J Goulis et al.

    Bacterial infection in the pathogenesis of variceal bleeding

    Lancet

    (1999)
  • G Soriano et al.

    Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal haemorrhage

    Gastroenterology

    (1992)
  • A Pauwels et al.

    Systemic antibiotic prophylaxis after gastrointestinal haemorrhage in cirrhotic patients with a high risk of infection

    Hepatology

    (1996)
  • WJ Hsieh et al.

    The effect of ciprofloxacin in the prevention of bacterial infections in patients with cirrhosis after upper gastrointestinal bleeding

    Am J Gastroenterol

    (1998)
  • M Merli et al.

    Cirrhotic patients are at risk for health care-associated bacterial infections

    Clin Gastroenterol Hepatol

    (2010)
  • B Bernard et al.

    Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

    Hepatology

    (1999)
  • H Yoshida et al.

    Bacterial infection in cirrhosis, with and without hepatocellular carcinoma

    Am J Gastroenterol

    (1993)
  • J Llach et al.

    Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration

    Hepatology

    (1992)
  • P Ginès et al.

    Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

    Hepatology

    (1990)
  • T Gustot et al.

    Severe sepsis in cirrhosis

    Hepatology

    (2009)
  • V Arvaniti et al.

    Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

    Gastroenterology

    (2010)
  • A Plessier et al.

    Coagulation disorders in patients with cirrhosis and severe sepsis

    Liver Int

    (2003)
  • RP Mookerjee et al.

    Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome

    Hepatology

    (2007)
  • R Wiest et al.

    Bacterial translocation (BT) in cirrhosis

    Hepatology

    (2005)
  • B Appenrodt et al.

    Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis

    Hepatology

    (2010)
  • I Altorjav et al.

    Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis

    J Hepatol

    (2010)
  • HD Nischalke et al.

    Toll-like receptor (TLR) 2 promotor and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis

    J Hepatol

    (2011)
  • J Deviere et al.

    Excessive in vitro bacterial lipolysaccharide-induced production of monkines in cirrhosis

    Hepatology

    (1990)
  • M Navasa et al.

    Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality

    Hepatology

    (1998)
  • G Tritto et al.

    Evidence of neutrophil functional defect despite inflammation in stable cirrhosis

    J Hepatol

    (2011)
  • PA Berres et al.

    Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis

    Liver Int

    (2009)
  • P Tandon et al.

    Bacterial infections, sepsis, and multiorgan failure in cirrhosis

    Semin Liver Dis

    (2008)
  • American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

    Crit Care Med

    (1992)
  • D Thabut et al.

    Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

    Hepatology

    (2007)
  • A Pfäfflin et al.

    Inflammation markers in point-of-care testing (POCT)

    Anal Bioanal Chem

    (2009)
  • B Müller et al.

    Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis

    J Clin Endocrinol Metab

    (2001)
  • CH Li et al.

    Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department

    Acad Emerg Med

    (2011)
  • I Mackenzie et al.

    C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction

    Intensive Care Med

    (2006)
  • Cited by (283)

    • Bacterial infections in cirrhosis: Challenges and perspectives

      2022, Acta Colombiana de Cuidado Intensivo
    • Vaccination in Chronic Liver Disease: An Update

      2022, Journal of Clinical and Experimental Hepatology
    • Peripheral vasculature in portal hypertension

      2022, Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease
    View all citing articles on Scopus
    View full text